MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting
Lung cancer remains a formidable global health burden, necessitating a comprehensive
understanding of the underlying molecular mechanisms driving its progression. Recently …
understanding of the underlying molecular mechanisms driving its progression. Recently …
A cross-talk about radioresistance in lung cancer—How to improve radiosensitivity according to Chinese medicine and medicaments that commonly occur in …
P Nowak, I Bil-Lula, M Śliwińska-Mossoń - International Journal of …, 2023 - mdpi.com
Lung cancer is one of the most common cancers in the population and is characterized by
non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological …
non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological …
[HTML][HTML] LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44
Background Radiotherapy is the primary treatment for patients with nasopharyngeal
carcinoma (NPC); however, almost 20% of patients experience treatment failure due to …
carcinoma (NPC); however, almost 20% of patients experience treatment failure due to …
Diagnostic value of lncRNA HOTAIR as a biomarker for detecting and staging of non-small cell lung cancer
X Yao, T Wang, MY Sun, Y Yuming, D Guixin, J Liu - Biomarkers, 2022 - Taylor & Francis
Background Since the role of long non-coding RNA (lncRNA) HOTAIR is yet to be
established in non-small cell lung cancer (NSCLC), we tried to explore the expression of …
established in non-small cell lung cancer (NSCLC), we tried to explore the expression of …
[HTML][HTML] Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis
B Wang, X Sun, KJ Huang, LS Zhou… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through
miRNA-128-3p/GOLM1 axis - PMC Back to Top Skip to main content NIH NLM Logo Access …
miRNA-128-3p/GOLM1 axis - PMC Back to Top Skip to main content NIH NLM Logo Access …
[HTML][HTML] Regulatory mechanisms and clinical applications of tumor-driven exosomal circRNAs in cancers
X Meng, D Yang, B Zhang, Y Zhao… - International Journal of …, 2023 - ncbi.nlm.nih.gov
Malignant tumors seriously affect people's survival and prognosis. Exosomes, as vesicle
structures widely existing in human tissues and body fluids, are involved in cell-to-cell …
structures widely existing in human tissues and body fluids, are involved in cell-to-cell …
Recent progress and the emerging role of lncRNAs in cancer drug resistance; focusing on signaling pathways
MJ Saadh, I Rasulova, MAA Almoyad… - … -Research and Practice, 2024 - Elsevier
It is becoming more and more apparent that many of the genetic alterations associated with
cancer are located in areas that do not encode proteins. lncRNAs are a class of RNAs that …
cancer are located in areas that do not encode proteins. lncRNAs are a class of RNAs that …
LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis
Y Xie, J Han, K Xie, Q Gou - Scientific Reports, 2022 - nature.com
The effect of long noncoding RNAs (lncRNAs) on the radiotherapy response has been
gradually revealed. This systematic review and meta-analysis aimed to evaluate the …
gradually revealed. This systematic review and meta-analysis aimed to evaluate the …
Lactobacillus rhamnosus GG ameliorates radiation-induced lung fibrosis via lncRNASNHG17/PTBP1/NICD axis modulation
Z Ju, H Pan, C Qu, L Xiao, M Zhou, Y Wang, J Luo… - Biology Direct, 2023 - Springer
Radiation-induced pulmonary fibrosis (RIPF) is a major side effect experienced for patients
with thoracic cancers after radiotherapy. RIPF is poor prognosis and limited therapeutic …
with thoracic cancers after radiotherapy. RIPF is poor prognosis and limited therapeutic …
Involvement of non-coding RNAs in chemo-and radioresistance of nasopharyngeal carcinoma
J Xiao, X He - Cancer management and research, 2021 - Taylor & Francis
The crucial treatment for nasopharyngeal carcinoma (NPC) is radiation therapy
supplemented by chemotherapy. However, long-term radiation therapy can cause some …
supplemented by chemotherapy. However, long-term radiation therapy can cause some …